G. Porzio

发表

Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series

C. Ficorella, A. Parisi, M. V. Pensieri, 2020, Journal of addictive diseases.

Prognostic value of p53 molecular status in high-risk primary breast cancer.

R. Bisegna, E. Ricevuto, P. Marchetti, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Bone recurrence in early breast cancer patients: The paradox of aromatase inhibitors induced bone resorption.

C. Ficorella, K. Cannita, A. Parisi, 2021, Breast disease.

Acupuncture in the Treatment of Menopause-related Symptoms in Women Taking Tamoxifen

P. Marchetti, C. Ficorella, G. Porzio, 2002, Tumori.

From adjuvant to preventive breast cancer treatment: bridging the gap over troubled waters.

E. Ricevuto, C. Ficorella, Z. C. di Rocco, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line.

E. Ricevuto, P. Marchetti, C. Ficorella, 2004, Anticancer research.

Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians’ practice

M. Filetti, P. Marchetti, C. Ficorella, 2019, Supportive Care in Cancer.

Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids

C. Ficorella, S. Mercadante, Claudio Adile, 2013, Current medical research and opinion.

Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients.

S. Mercadante, L. Verna, G. Porzio, 2009, The journal of pain : official journal of the American Pain Society.

Triplet chemotherapy in patients with metastatic colorectal cancer: toward the best way to safely administer a highly active regimen in clinical practice.

N. Tinari, E. Ricevuto, C. Ficorella, 2012, Clinical colorectal cancer.

Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II study.

S. Iacobelli, E. Ricevuto, P. Marchetti, 2010, Oncology reports.

Increased tolerability of bimonthly 12-hour timed flat infusion 5-fluorouracil/irinotecan regimen in advanced colorectal cancer: A dose-finding study.

N. Tinari, S. Iacobelli, E. Ricevuto, 2006, Oncology reports.

Topical Menthol for Treatment of Chemotherapy-induced Peripheral Neuropathy

C. Ficorella, K. Cannita, A. Parisi, 2017, Indian journal of palliative care.

Predictive Ability for Disease-Free Survival of the GRade, Age, Nodes, and Tumor (GRANT) Score in Patients with Resected Renal Cell Carcinoma.

N. Tinari, C. Ficorella, K. Cannita, 2020, Current urology.

Multimodality Treatment in Metastatic Gastric Cancer: From Past to Next Future

C. Ficorella, A. Parisi, G. Porzio, 2020, Cancers.

Sustained‐release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management

C. Ficorella, F. Fulfaro, S. Mercadante, 2008, European journal of pain.

Non Clinical Factors as Determinants of the Use of Breast Conservative Surgery in Italy

G. Porzio, 2003, Tumori.

Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey

M. Filetti, P. Marchetti, A. Cortellini, 2021, Supportive Care in Cancer.

Home care for cancer patients after an earthquake: the experience of the "L'Aquila per la Vita" Home Care Unit.

E. Ricevuto, C. Ficorella, K. Cannita, 2011, Journal of pain and symptom management.

Sleep Disturbances in Patients With Advanced Cancer in Different Palliative Care Settings.

M. Valenti, F. Masedu, C. Ficorella, 2015, Journal of pain and symptom management.

Use of strong opioids in advanced cancer pain: a randomized trial.

P. Marchetti, A. Paladini, G. Varrassi, 2004, Journal of pain and symptom management.

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study

M. Piccart, M. Filetti, R. Salazar, 2022, The Lancet Oncology.

Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain–Barré Syndrome

C. Ficorella, K. Cannita, A. Parisi, 2018, Case reports in oncological medicine.

Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study

M. Maltoni, S. Barni, L. Cavanna, 2020, Journal of clinical medicine.

Opioid switching in patients with advanced cancer followed at home. A retrospective analysis.

S. Mercadante, Claudio Adile, G. Porzio, 2013, Journal of pain and symptom management.

A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?

C. Ficorella, P. Antonetti, A. Parisi, 2021, Supportive Care in Cancer.

Efficacy of pregabalin in the management of cetuximab-related itch.

C. Ficorella, K. Cannita, L. Verna, 2006, Journal of pain and symptom management.

Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study

N. Tinari, E. Ricevuto, P. Marchetti, 2004, British Journal of Cancer.

Pain evaluation and management: a survey of Italian radiotherapists

M. Valenti, E. Ricevuto, P. Marchetti, 2005, Supportive Care in Cancer.

The Incidence of Alcoholism in Patients with Advanced Cancer Receiving Active Treatment in Two Tertiary Care Centers in Italy

P. Marchetti, L. Verna, G. Porzio, 2018, Alcohol and alcoholism.

Pattern of symptoms and symptomatic treatment in adults and the aged population: a retrospective analysis of advanced cancer patients followed at home

M. Valenti, F. Masedu, S. Mercadante, 2016, Current medical research and opinion.

Pain Characteristics and Analgesic Treatment in an Aged Adult Population: A 4-Week Retrospective Analysis of Advanced Cancer Patients Followed at Home

M. Valenti, F. Masedu, C. Ficorella, 2015, Drugs & Aging.

Efficacy and safety of deep, continuous palliative sedation at home: a retrospective, single-institution study

C. Ficorella, L. Verna, G. Porzio, 2009, Supportive Care in Cancer.

Gratitude among advanced cancer patients and their caregivers: The role of early palliative care

E. Bruera, Sarah Bigi, M. Luppi, 2022, Frontiers in Oncology.

Tapentadol in cancer pain management: a prospective open-label study

C. Ficorella, S. Mercadante, Claudio Adile, 2012, Current medical research and opinion.

Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice

D. Mallardo, P. Ascierto, P. Marchetti, 2019, Journal of Translational Medicine.

[The adjuvant therapy of colonic carcinoma in old age].

E. Ricevuto, P. Marchetti, C. Ficorella, 1999, Minerva medica.

Inappropriate doses of chemotherapy in Italian breast cancer patients enrolled in clinical trials.

F. Roila, P. Marchetti, G. Porzio, 2007, Tumori.

Cerebral metastasis from ovarian cancer treated with a multidisciplinary approach. Case report and review of literature.

C. Ficorella, G. Porzio, P. Marchetti, 2003, European journal of gynaecological oncology.

Is There Still a Role for the Uniscale Assessment of Quality of Life?

F. Roila, G. Porzio, A. Mattei, 2007, Tumori.

Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy

M. Filetti, L. Landi, G. Minuti, 2021, Journal for ImmunoTherapy of Cancer.

Immune Checkpoint Inhibitors and Myasthenic Syndromes: A Case Report of a Metastatic Renal Cell Carcinoma Patient Treated With Nivolumab.

C. Ficorella, A. Parisi, A. Cortellini, 2018, Journal of clinical neuromuscular disease.

Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study.

M. Filetti, L. Landi, G. Minuti, 2021, European journal of cancer.

Palliative sedation in patients with advanced cancer followed at home: a systematic review.

S. Mercadante, G. Porzio, A. Valle, 2011, Journal of pain and symptom management.

Hypersensitivity reaction to carboplatin: successful resolution by replacement with cisplatin.

E. Ricevuto, P. Marchetti, C. Ficorella, 2002, European journal of gynaecological oncology.

Effective analgesic score: a "marker" of the effects of chemotherapy on pain in advanced cancer patients?

C. Ficorella, K. Cannita, L. Verna, 2007, Journal of pain and symptom management.

Spinal analgesia for advanced cancer patients: an update.

S. Mercadante, G. Porzio, V. Gebbia, 2012, Critical reviews in oncology/hematology.

Breakthrough pain in oncology: a longitudinal study.

S. Mercadante, G. Porzio, V. Gebbia, 2010, Journal of pain and symptom management.

Age differences in the last week of life in advanced cancer patients followed at home

M. Valenti, F. Masedu, S. Mercadante, 2016, Supportive Care in Cancer.

New opioids.

S. Mercadante, G. Porzio, V. Gebbia, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Palliative sedation in patients with advanced cancer followed at home: a prospective study.

S. Mercadante, G. Porzio, A. Casuccio, 2014, Journal of pain and symptom management.

Integrating oncology and palliative home care in Italy: the experience of the "L'Aquila per la Vita" Home Care Unit.

C. Ficorella, F. Martella, L. Verna, 2013, Tumori.

How do cancer patients receiving palliative care at home die? A descriptive study.

S. Mercadante, G. Porzio, A. Casuccio, 2011, Journal of pain and symptom management.

The Supportive Care Task Force at the University of L’Aquila: 2-years experience

E. Ricevuto, P. Marchetti, C. Ficorella, 2005, Supportive Care in Cancer.

Pain Intensity as Prognostic Factor in Cancer Pain Management

S. Mercadante, G. Porzio, A. Cortegiani, 2015, Pain practice : the official journal of World Institute of Pain.

The Effects of Low Doses of Pregabalin on Morphine Analgesia in Advanced Cancer Patients

S. Mercadante, G. Porzio, C. Lo Presti, 2013, The Clinical journal of pain.

Does pain intensity predict a poor opioid response in cancer patients?

C. Ficorella, S. Mercadante, L. Verna, 2011, European journal of cancer.

Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.

S. Mercadante, L. Verna, G. Porzio, 2006, Journal of pain and symptom management.

Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study

N. Tinari, M. Tiseo, C. Ficorella, 2019, Biomedical reports.

The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy

M. Maltoni, E. Scarpi, A. Caraceni, 2008, Supportive Care in Cancer.

Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients

M. Valenti, F. Masedu, S. Mercadante, 2015, Supportive Care in Cancer.

Switching from transdermal drugs: an observational "N of 1" study of fentanyl and buprenorphine.

C. Ficorella, F. Fulfaro, S. Mercadante, 2007, Journal of pain and symptom management.

Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study

N. Tinari, M. Filetti, D. Mallardo, 2020, Oncoimmunology.

Octreotide for malignant bowel obstruction: twenty years after.

S. Mercadante, G. Porzio, 2012, Critical reviews in oncology/hematology.

The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer

M. Filetti, L. Landi, G. Minuti, 2021, ESMO open.

Rapid resolution of refractory chemotherapy-induced oral mucositis with platelet gel-released supernatant in a pediatric cancer patient: a case report.

C. Ficorella, G. Porzio, R. Giusti, 2014, Journal of pain and symptom management.

Comment on ‘What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain: Expert Opinion’

C. Ficorella, L. Verna, G. Porzio, 2016, Drugs.

Clinicians' Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, "Real-Life", Case-Control Study.

N. Tinari, G. Tortora, C. Ficorella, 2021, Clinical colorectal cancer.

Evaluation of Second-Line Anti-VEGF after First-Line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter “SLAVE” Study

N. Tinari, G. Tortora, P. Marchetti, 2020, Cancers.

Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study

G. Tortora, C. Ficorella, A. Parisi, 2021, Frontiers in Oncology.

Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation

M. Filetti, V. Adamo, M. Tiseo, 2021, Cancer Immunology, Immunotherapy.

Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index.

M. Filetti, D. Mallardo, P. Ascierto, 2020, European journal of cancer.

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

M. Filetti, D. Mallardo, P. Ascierto, 2020, Journal for ImmunoTherapy of Cancer.

Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation

M. Filetti, L. Landi, J. Aerts, 2020, Journal for ImmunoTherapy of Cancer.

M. Filetti, L. Landi, F. Cappuzzo, 2020, Clinical lung cancer.

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%

M. Filetti, L. Landi, F. Cappuzzo, 2020, Cancer Immunology, Immunotherapy.

M. Filetti, D. Galetta, V. Adamo, 2020, medRxiv.

Clinicopathologic correlates of pembrolizumab efficacy in patients with advanced NSCLC and a PD-L1 expression of >= 50%.

M. Filetti, L. Landi, F. Cappuzzo, 2020, medRxiv.

Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events.

M. Filetti, D. Mallardo, P. Ascierto, 2020, European journal of cancer.

Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study

N. Tinari, J. McQuade, F. Bozzetti, 2020, Scientific Reports.

Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes

M. Filetti, D. Galetta, G. Banna, 2019, Clinical and Translational Oncology.

Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study

N. Tinari, P. Marchetti, C. Ficorella, 2019, Journal of Cancer Research and Clinical Oncology.

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients.

N. Tinari, M. Filetti, M. Tiseo, 2019, Clinical lung cancer.

First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience

C. Ficorella, K. Cannita, A. Parisi, 2019, Clinical and Translational Oncology.

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

N. Tinari, M. Filetti, P. Ascierto, 2019, Journal of Immunotherapy for Cancer.

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study.

N. Tinari, M. Filetti, P. Ascierto, 2019, The oncologist.

Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non‐small cell lung cancer patients: A “hypothesis‐generator” preliminary report

N. Tinari, F. Bozzetti, C. Ficorella, 2019, Thoracic cancer.

Single‐institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non‐small cell lung cancer patients treated with first‐line chemotherapy

F. Bozzetti, C. Ficorella, K. Cannita, 2018, Thoracic cancer.

Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomized, Crossover, Comparison Study.

S. Mercadante, G. Porzio, A. Cortegiani, 2015, Journal of pain and symptom management.

Reducing breast cancer incidence in familial breast cancer: overlooking the present panorama.

R. Bisegna, E. Ricevuto, P. Marchetti, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Physical Exercise and Quality of Life in Breast Cancer Survivors

M. Valenti, F. Masedu, P. Marchetti, 2008, International journal of medical sciences.

Prognostic value of p 53 molecular status in high-risk primary breast cancer

R. Bisegna, E. Ricevuto, P. Marchetti, 2003 .

Where are we with treatment options after first line in small cell lung cancer?-report of two opposite cases treated with CAPTEM regimen and possible perspectives.

C. Ficorella, G. Collina, K. Cannita, 2018, Journal of thoracic disease.

The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting

C. Ficorella, S. Mercadante, G. Porzio, 2013, Supportive Care in Cancer.

Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy.

M. Filetti, L. Landi, G. Minuti, 2021, European journal of cancer.

Epidemiology and Characteristics of Episodic Breathlessness in Advanced Cancer Patients: An Observational Study.

M. Valenti, F. Masedu, P. Marchetti, 2016, Journal of pain and symptom management.

Emergencies in patients with advanced cancer followed at home.

S. Mercadante, G. Porzio, A. Casuccio, 2012, Journal of pain and symptom management.

Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies

C. Ficorella, S. Mercadante, G. Porzio, 2013, Current medical research and opinion.

Integration between oncology and palliative care: does one size fit all?

C. Ficorella, L. Verna, G. Porzio, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis-generator’ study from clinical practice

C. Ficorella, K. Cannita, A. Parisi, 2018, Oncology letters.

What Is Known about Theragnostic Strategies in Colorectal Cancer

C. Ficorella, K. Cannita, A. Parisi, 2021, Biomedicines.

Home Care for Cancer Patients During COVID-19 Pandemic: The Double Triage Protocol

E. Bruera, A. Cortellini, L. Verna, 2020, Journal of Pain and Symptom Management.

Prognostic factors of survival in patients with advanced cancer admitted to home care.

S. Mercadante, G. Porzio, A. Casuccio, 2013, Journal of pain and symptom management.

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry

M. Piccart, M. Filetti, F. Grosso, 2023, The Lancet Oncology.

Can malignant bowel obstruction in advanced cancer patients be treated at home?

C. Ficorella, L. Verna, G. Porzio, 2011, Supportive Care in Cancer.

Cervical sarcoma botryoides treated with conservative surgery and adjuvant chemotherapy: a case report.

E. Ricevuto, C. Ficorella, I. Paris, 2000, European journal of gynaecological oncology.

Orphan symptoms in advanced cancer patients followed at home

S. Mercadante, G. Porzio, A. Casuccio, 2013, Supportive Care in Cancer.

Gabapentin in the Treatment of Hiccups in Patients With Advanced Cancer: A 5-Year Experience

C. Ficorella, L. Verna, G. Porzio, 2010, Clinical neuropharmacology.

Hiccup in patients with advanced cancer successfully treated with gabapentin: report of three cases.

E. Ricevuto, P. Marchetti, C. Ficorella, 2003, The New Zealand medical journal.

Gabapentin in the treatment of severe sweating experienced by advanced cancer patients

E. Ricevuto, P. Marchetti, C. Ficorella, 2006, Supportive Care in Cancer.

PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort

M. Filetti, D. Mallardo, P. Ascierto, 2021, Journal of translational medicine.

Early palliative care for solid and blood cancer patients and caregivers: Quantitative and qualitative results of a long-term experience as a case of value-based medicine

Sarah Bigi, M. Luppi, G. Porzio, 2023, Frontiers in Public Health.

Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity

E. Ricevuto, C. Ficorella, K. Cannita, 2003, British Journal of Cancer.

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status

M. Filetti, V. Adamo, J. Aerts, 2022, Journal of Hematology & Oncology.

Dosing fentanyl buccal tablet for breakthrough cancer pain: dose titration versus proportional doses

S. Mercadante, G. Porzio, C. Lo Presti, 2012, Current medical research and opinion.

The Medical Oncologist's Role in Palliative Care: AIOM's Position

M. Maltoni, L. Cavanna, P. Marchetti, 2009, Tumori.

Original article Tapentadol in cancer pain management: a prospective open-label study

S. Mercadante, G. Porzio, P. Ferrera, 2012 .

Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain

A. Dickenson, S. Mercadante, G. Porzio, 2014, Current medical research and opinion.

Brief report Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain

S. Mercadante, G. Porzio, C. Adile, 2014 .

Immigrants Accessing End-of-Life Care in Italy: The Tuscany Tumor Association Experience.

L. Verna, G. Porzio, R. Giusti, 2016, Journal of Pain and Symptom Management.

Is there a role for neurologist in an oncological home care team?

C. Ficorella, F. Martella, L. Verna, 2012, Neurological Sciences.

Host immune‐inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer and poor performance status receiving first‐line immunotherapy

F. Cappuzzo, J. Aerts, F. Mazzoni, 2021, Thoracic cancer.

Corrigendum to ‘The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer’

M. Filetti, L. Landi, G. Minuti, 2021, ESMO open.

Smoking status during first‐line immunotherapy and chemotherapy in NSCLC patients: A case–control matched analysis from a large multicenter study

M. Filetti, L. Landi, G. Minuti, 2021, Thoracic cancer.

Integration between Oncology and Palliative Care: A Plan for the Next Decade?

C. Ficorella, L. Verna, G. Porzio, 2017, Tumori.

COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry

R. Salazar, F. Mazzoni, N. Harbeck, 2021, Therapeutic advances in medical oncology.

Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice

D. Mallardo, P. Ascierto, P. Marchetti, 2019, Journal of Translational Medicine.

Central Nervous System Tumors

F. Martella, G. Porzio, D. Cerone, 2012 .

Family History of Cancer as Potential Prognostic Factor in Stage III Colorectal Cancer: a Retrospective Monoinstitutional Study

C. Ficorella, K. Cannita, A. Parisi, 2020, Journal of Gastrointestinal Cancer.

The PERSONS score: A new tool for cancer patients’ symptom assessment in simultaneous care and home care settings

C. Ficorella, A. Parisi, A. Cortellini, 2020, Palliative and Supportive Care.

The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study

C. Ficorella, A. Parisi, A. Cortellini, 2018, Palliative and Supportive Care.

Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors

M. Maltoni, E. Scarpi, M. Filetti, 2020, Supportive Care in Cancer.

[Hormone substitution therapy during menopause. Increase of compliance].

G. Porzio, F. Patacchiola, M. Moscarini, 1997, Minerva ginecologica.

Cancer Care After Natural Disaster: Different Countries, Similar Problems

C. Ficorella, A. Cortellini, L. Verna, 2019, Journal of global oncology.

The frequency of alcoholism in patients with advanced cancer admitted to an acute palliative care unit and a home care program.

S. Mercadante, G. Porzio, A. Casuccio, 2015, Journal of pain and symptom management.

Into the storms: Organising oncological home care services during natural disasters and global pandemics.

A. Parisi, A. Cortellini, L. Verna, 2021, European journal of cancer care.

Caring for Cancer Patients After the Italian Earthquakes: A Proposal From the Field

L. Verna, G. Porzio, Rosa R. Silva, 2017, Disaster Medicine and Public Health Preparedness.

Timed‑flat infusion of 5‑fluorouracil with docetaxel and oxaliplatin as first‑line treatment of gastroesophageal adenocarcinoma: A single institution experience with the FD/FOx regimen.

C. Ficorella, K. Cannita, A. Parisi, 2018, Oncology reports.

Opioids applied topically to painful cutaneous malignant ulcers in a palliative care setting.

G. Porzio, G. Zeppetella, F. Aielli, 2007, Journal of Opioid Management.

Knowledge and attitudes of Italian medical oncology residents toward the approach and treatment of pain.

M. Valenti, P. Marchetti, G. Varrassi, 2003, Journal of pain and symptom management.

Pruritus in a patient with advanced cancer successfully treated with continuous infusion of granisetron

D. Piccolo, P. Marchetti, K. Cannita, 2004, Supportive Care in Cancer.

Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.

S. Mercadante, L. Verna, G. Porzio, 2006, Journal of pain and symptom management.

Palliative sedation in advanced cancer patients followed at home: a retrospective analysis.

S. Mercadante, G. Porzio, A. Casuccio, 2012, Journal of pain and symptom management.

Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study

N. Tinari, J. McQuade, F. Bozzetti, 2020, Scientific Reports.

Triplet chemotherapy in patients with metastatic colorectal cancer: toward the best way to safely administer a highly active regimen in clinical practice.

N. Tinari, E. Ricevuto, C. Ficorella, 2012, Clinical colorectal cancer.

Surgical treatment of invasive carcinoma of the vulva. Our experience.

G. Porzio, F. Patacchiola, G. Carta, 2000, European journal of gynaecological oncology.

Topical Menthol for Treatment of Chemotherapy-induced Peripheral Neuropathy

C. Ficorella, K. Cannita, A. Parisi, 2017, Indian journal of palliative care.

Assessment and treatment of symptoms among Italian medical oncologists

M. Valenti, E. Ricevuto, P. Marchetti, 2005, Supportive Care in Cancer.

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

M. Filetti, R. Salazar, A. Maconi, 2022, European Journal of Cancer.

Pain Intensity as Prognostic Factor in Cancer Pain Management

S. Mercadante, G. Porzio, A. Cortegiani, 2015, Pain practice : the official journal of World Institute of Pain.

Short-Term Weekly Neoadjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer

E. Ricevuto, P. Marchetti, C. Ficorella, 2001, Tumori.

Multidisciplinary approach, continuous care and opioid management in cancer pain: case series and review of the literature.

G. Porzio, M. Moro, R. Giusti, 2023, Drugs in context.